{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:13:45Z","timestamp":1753888425349},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dmidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.diagmicrobio.2015.03.014","type":"journal-article","created":{"date-parts":[[2015,5,2]],"date-time":"2015-05-02T17:55:16Z","timestamp":1430589316000},"page":"245-248","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Decreasing prevalence of isolates with vancomycin heteroresistance and vancomycin minimum inhibitory concentrations \u22652mg\/L in methicillin-resistant Staphylococcus aureus over 11years: potential impact of vancomycin treatment guidelines"],"prefix":"10.1016","volume":"82","author":[{"given":"Riad","family":"Khatib","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamta","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard B.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Riederer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Shemes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Szpunar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2015.03.014_bb0005","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/jac\/dkn246","article-title":"Vancomycin MICs did not creep in Staphylococcus aureus isolates from 2002 to 2006 in a setting with low vancomycin usage","volume":"62","author":"Alos","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2015.03.014_bb0010","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/AAC.01516-13","article-title":"In vitro pharmacodynamics of human simulated exposures of ceftraoline and daptomycin against MRSA, hVISA and VISA with and without prior vancomycin exposure","volume":"58","author":"Bhalodi","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2015.03.014_bb0015","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1128\/AAC.05609-11","article-title":"Vancomycin AUC24\/MIC ratio in patients with complicated bacteremia and infective endocarditis due to methicillin-resistant Staphylococcus aureus and its association with attributable mortality during hospitalization","volume":"56","author":"Brown","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2015.03.014_bb0020","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/cid\/cis717","article-title":"Methicillin-resistant Staphylococcus aureus cassette chromosome mec genotype effects outcomes of patients with healthcare-associated MRSA bacteremia independently of vancomycin minimum inhibitory concentrations","volume":"55","author":"Chen","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2015.03.014_bb0025","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/jac\/dkt395","article-title":"Reduced susceptibility to vancomycin in isogenic Staphylococcus aureus strains of sequence type 59: tracking evolution and identifying mutations by whole-genome sequencing","volume":"69","author":"Chen","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2015.03.014_bb0030","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1128\/JCM.00154-08","article-title":"Molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates in urban Detroit","volume":"46","author":"Chua","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2015.03.014_bb0035","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1128\/JCM.05520-11","article-title":"Is vancomycin MIC \u201ccreep\u201d method dependent? Analysis of methicillin-resistant Staphylococcus aureus susceptibility trends in blood isolates from north east Scotland from 2006 to 2010","volume":"50","author":"Edwards","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2015.03.014_bb0040","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MD.0b013e31822f0b54","article-title":"Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection: secular trends over 19years at a university hospital","volume":"90","author":"Gasch","year":"2011","journal-title":"Medicine"},{"key":"10.1016\/j.diagmicrobio.2015.03.014_bb0045","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1093\/jac\/dks255","article-title":"Reduced vancomycin susceptibility and staphylococcal cassette chromosome mec (SCCmec) type and distribution in methicillin-resistant Staphylococcus aureus bacteremia","volume":"67","author":"Han","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2015.03.014_bb0050","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1128\/AAC.00945-07","article-title":"Inhibitory activities of 11 antimicrobial agents and bactericidal activities of vancomycin and daptomycin against methicillin-resistant Staphylococcus isolates obtained from 1999 through 2006","volume":"52","author":"Holmes","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"S1","key":"10.1016\/j.diagmicrobio.2015.03.014_bb0055","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1086\/491710","article-title":"Microbiological features if vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal\/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains","volume":"42","author":"Jones","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2015.03.014_bb0060","doi-asserted-by":"crossref","first-page":"129","DOI":"10.5799\/jmid.123125","article-title":"An optimal method for generating stable vancomycin heteroresistance and intermediate susceptibility in methicillin-resistant Staphylococcus aureus blood isolates under in-vitro vancomycin pressure","volume":"2","author":"Khatib","year":"2012","journal-title":"J Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2015.03.014_bb0065","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ajic.2012.03.038","article-title":"Decreasing incidence of Staphylococcus aureus bacteremia over 9years: greatest decline in community-associated methicillin-susceptible and hospital-acquired methicillin-resistant isolates","volume":"41","author":"Khatib","year":"2013","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.diagmicrobio.2015.03.014_bb0070","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1086\/669868","article-title":"Comparative epidemiology of bacteremia due to methicillin-resistant Staphylococcus aureus between older and younger adults: a propensity score analysis","volume":"34","author":"Kullar","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.diagmicrobio.2015.03.014_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/cir034","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2015.03.014_bb0080","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/cid\/cir858","article-title":"An association between bacterial genotype combined with a high-vancomycin minimum inhibitory concentration and risk of endocarditis in methicillin-resistant Staphylococcus aureus bloodstream infection","volume":"54","author":"Miller","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2015.03.014_bb0085","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/cid\/cir764","article-title":"Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with high vancomycin minimum inhibitory concentration: a case\u2013control study","volume":"54","author":"Moore","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2015.03.014_bb0090","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1128\/JCM.02135-08","article-title":"Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: trends over 11years","volume":"47","author":"Musta","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2015.03.014_bb0095","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1128\/JCM.00914-10","article-title":"Vancomycin susceptibility trends and prevalence of vancomycin-intermediate Staphylococcus aureus in clinical methicillin-resistant S. aureus isolates","volume":"49","author":"Pitz","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2015.03.014_bb0100","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1128\/AAC.01915-13","article-title":"Activity of vancomycin, ceftraoline, and mupricin against Staphylococcus aureus isolates collected in a 2011 national surveillance study in the United States","volume":"58","author":"Richter","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2015.03.014_bb0105","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1128\/JCM.01435-10","article-title":"Detection of intermediately vancomycin-susceptible and heterogeneous Staphylococcus aureus isolates: comparison of Etest and agar screening methods","volume":"49","author":"Riederer","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2015.03.014_bb0110","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJMoa1303359","article-title":"Transferable vancomycin resistance in a community-associated MRSA lineage","volume":"370","author":"Rossi","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diagmicrobio.2015.03.014_bb0115","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1128\/AAC.00616-09","article-title":"Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus isolates collected in nine U.S. medical centers from 2002 to 2006","volume":"53","author":"Sader","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2015.03.014_bb0135","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3109\/00365548.2013.847530","article-title":"What is the reason for conflicting results for vancomycin minimum inhibitory concentration values for methicillin-resistant Staphylococcus aureus","volume":"46","author":"Sancak","year":"2014","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2015.03.014_bb0125","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1186\/1471-2334-13-583","article-title":"Vancomycin and daptomycin minimum inhibitory concentration distribution and occurrence of heteroresistance among methicillin-resistant Staphylococcus aureus blood isolates in Turkey","volume":"13","author":"Sancak","year":"2013","journal-title":"BMJ Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2015.03.014_bb0130","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkt247","article-title":"Evaluation of vancomycin and daptomycin MIC trends for methicillin-resistant Staphylococcus aureus blood isolates over an 11year","author":"Sancak","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"S1","key":"10.1016\/j.diagmicrobio.2015.03.014_bb0120","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1093\/cid\/cit613","article-title":"Methicillin-resistant Staphylococcus aureus: an evolving pathogen","volume":"58","author":"Stryjewski","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2015.03.014_bb0140","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1186\/1471-2334-14-459","article-title":"First case of vancomycin-intermediate sequence type 72 Staphylococcus aureus with non-susceptibility to daptomycin","volume":"14","author":"Tsukimori","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2015.03.014_bb0145","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1093\/jac\/dkr280","article-title":"Methicillin-resistant Staphylococcus aureus vancomycin susceptibility testing: methodology correlations, temporal trends and clonal patterns","volume":"66","author":"van Hal","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2015.03.014_bb0150","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1128\/JCM.43.10.5026-5033.2005","article-title":"Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette mec types I to V in methicillin-resistant Staphylococcus aureus","volume":"43","author":"Zhang","year":"2005","journal-title":"J Clin Microbiol"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889315001054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889315001054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T13:09:31Z","timestamp":1566652171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889315001054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0732889315001054"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2015.03.014","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreasing prevalence of isolates with vancomycin heteroresistance and vancomycin minimum inhibitory concentrations \u22652mg\/L in methicillin-resistant Staphylococcus aureus over 11years: potential impact of vancomycin treatment guidelines","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2015.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}